PAPER Cavallaro V, Alza NP, Murray MG, Murray AP
SEARCH RESULTS
330026 RESULTS
PAPER Shen JN, Xu LX, Wang R
[Cyclooxygenases, lipoxygenases, their targeted drugs and the prevention of Alzheimer's disease].
Yao Xue Xue Bao. 2013 Dec;48(12):1743-54. PubMed: 24689230PAPER De W, Nie F, Huang H, Yan J, Risacher SL, Saykin AJ, Shen L
Structural brain network constrained neuroimaging marker identification for predicting cognitive functions.
Inf Process Med Imaging. 2013;23:536-47. PubMed: 24683997PAPER
Health tips. Finding balance in Alzheimer's caregiving.
Mayo Clin Health Lett. 2013 Feb;31(2):3. PubMed: 24683626PAPER Uppalapati D, Das NR, Gangwal RP, Damre MV, Sangamwar AT, Sharma SS
Neuroprotective Potential of Peroxisome Proliferator Activated Receptor- α Agonist in Cognitive Impairment in Parkinson's Disease: Behavioral, Biochemical, and PBPK Profile.
PPAR Res. 2014;2014:753587. Epub 2014 Feb 19 PubMed: 24693279PAPER Rosenberg GA, Bjerke M, Wallin A
Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.
Stroke. 2014 May;45(5):1531-8. Epub 2014 Apr 1 PubMed: 24692476PAPER Numans ME, Wind A
[Do not screen all elderly for cognitive impairment].
Ned Tijdschr Geneeskd. 2014;158:A7334. PubMed: 24690520PAPER Ho SC, Hsu CC, Yu CH, Huang WN, Tikhonova MA, Ho MC, Hung CS, Amstislavskaya TG, Ho YJ
Measuring attention in a Parkinson's disease rat model using the 5-arm maze test.
Physiol Behav. 2014 May 10;130:176-81. Epub 2014 Mar 30 PubMed: 24690450PAPER Sodhi RK, Singh N
Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia.
Eur J Pharmacol. 2014 Jun 5;732:50-9. Epub 2014 Mar 29 PubMed: 24690259PAPER Gupta S, Sharma B
Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
Eur J Pharmacol. 2014 Jun 5;732:111-22. Epub 2014 Mar 29 PubMed: 24690258PAPER Sprung J, Knopman D, Warner DO, Knopman D, Warner DO
Risk of dementia after anaesthesia and surgery: study design may affect reported outcome.
Br J Psychiatry. 2014 Apr;204:323. PubMed: 24692755PAPER Kim JS, Oh YS, Lee KS, Song IU, Park IS, Yang DW, Koo JS, Goldstein DS
Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease.
J Neural Transm. 2014 Apr 2; PubMed: 24692006PAPER Palmal S, Maity AR, Singh BK, Basu S, Jana NR, Jana NR
Inhibition of Amyloid Fibril Growth and Dissolution of Amyloid Fibrils by Curcumin-Gold Nanoparticles.
Chemistry. 2014 Apr 1; PubMed: 24691975PAPER Magdalinou N, Lees AJ, Zetterberg H
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
J Neurol Neurosurg Psychiatry. 2014 Apr 1; PubMed: 24691581PAPER Brunet M
Targets for dementia diagnoses will lead to overdiagnosis.
BMJ. 2014 Apr 1;348:g2224. PubMed: 24690626Current Filters
No filters selected